Sphene Capital Cuts AlzChem Price Target to EUR 198.40 From EUR 204.50

Bitget2026/10/30 10:13

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Sphene Capital cut AlzChem's 24-month price target to EUR 198.40 from EUR 204.50 on October 30, 2026, retaining Buy.
The 3% target reduction reflected slightly weaker-than-expected earnings; the revised target implies 22.8% upside, excluding dividends.
Third-quarter growth remained driven by Specialty Chemicals, while weak demand and higher costs weighed on Basics & Intermediates.
Higher investment costs for the planned US nitroguanidine plant require renegotiations with the US War Department, according to the report.
Full-year 2026 guidance was reaffirmed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AlzChem Group AG published the original content used to generate this news brief via EQS News (Ref. ID: rc_27246) on October 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Sphene Capital Cuts AlzChem Price Target to EUR 198.40 From EUR 204.50

You may also like

Crypto prices